Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 476

1.

Evaluation of risk factors for elevated tricyclic antidepressant plasma concentrations.

Billups SJ, Delate T, Dugan D.

Pharmacoepidemiol Drug Saf. 2009 Mar;18(3):253-7. doi: 10.1002/pds.1697.

PMID:
19148878
2.
3.

Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.

Laine K, Tybring G, Härtter S, Andersson K, Svensson JO, Widén J, Bertilsson L.

Clin Pharmacol Ther. 2001 Oct;70(4):327-35.

PMID:
11673748
4.

Managing rapid metabolizers of antidepressants.

Kraus RP, Diaz P, McEachran A.

Depress Anxiety. 1996-1997;4(6):320-7.

PMID:
9166660
5.

Tricyclic antidepressant-induced seizures and plasma drug concentration.

Preskorn SH, Fast GA.

J Clin Psychiatry. 1992 May;53(5):160-2.

PMID:
1592842
6.

Effect of adjunctive paroxetine on serum levels and side-effects of tricyclic antidepressants in depressive inpatients.

Leucht S, Hackl HJ, Steimer W, Angersbach D, Zimmer R.

Psychopharmacology (Berl). 2000 Jan;147(4):378-83.

PMID:
10672631
7.

Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers.

Skinner MH, Kuan HY, Pan A, Sathirakul K, Knadler MP, Gonzales CR, Yeo KP, Reddy S, Lim M, Ayan-Oshodi M, Wise SD.

Clin Pharmacol Ther. 2003 Mar;73(3):170-7.

PMID:
12621382
8.

Economic appraisal of citalopram in the management of single-episode depression.

Sclar DA, Skaer TL, Robison LM, Galin RS.

J Clin Psychopharmacol. 1999 Oct;19(5 Suppl 1):47S-54S.

PMID:
10507508
9.

Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.

Kennedy SH, McCann SM, Masellis M, McIntyre RS, Raskin J, McKay G, Baker GB.

J Clin Psychiatry. 2002 Mar;63(3):181-6.

PMID:
11926715
10.

[Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].

Bonin B, Bertschy G, Baumann P, Francois T, Vandel P, Vandel S, Sechter D, Bizouard P.

Encephale. 1996 May-Jun;22(3):221-7. French.

PMID:
8767051
11.

[Toxic tricyclic drug plasma level caused by fluoxetine].

Hambrecht M.

Psychiatr Prax. 1995 Nov;22(6):252-3. German.

PMID:
8570758
12.

Dosing of antidepressants--the unknown art.

Jerling M.

J Clin Psychopharmacol. 1995 Dec;15(6):435-9.

PMID:
8748433
13.

Compliance in depressed patients treated with fluoxetine or amitriptyline. Belgian Compliance Study Group.

Demyttenaere K, Van Ganse E, Gregoire J, Gaens E, Mesters P.

Int Clin Psychopharmacol. 1998 Jan;13(1):11-7.

PMID:
9988362
14.

Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment.

Pollock BG, Laghrissi-Thode F, Wagner WR.

J Clin Psychopharmacol. 2000 Apr;20(2):137-40.

PMID:
10770450
15.

Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants.

Bijl MJ, Visser LE, Hofman A, Vulto AG, van Gelder T, Stricker BH, van Schaik RH.

Br J Clin Pharmacol. 2008 Apr;65(4):558-64. Epub 2007 Dec 7.

16.

Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline.

Modell JG, Katholi CR, Modell JD, DePalma RL.

Clin Pharmacol Ther. 1997 Apr;61(4):476-87.

PMID:
9129565
17.

Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.

Alvarez JC, Gluck N, Arnulf I, Quintin P, Leboyer M, Pecquery R, Launay JM, Perez-Diaz F, Spreux-Varoquaux O.

Clin Pharmacol Ther. 1999 Dec;66(6):617-24.

PMID:
10613618
18.

Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture.

Vestergaard P, Rejnmark L, Mosekilde L.

Calcif Tissue Int. 2008 Feb;82(2):92-101. doi: 10.1007/s00223-007-9099-9. Epub 2008 Jan 25.

PMID:
18219438
19.

Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse.

Rao ML, Deister A, Laux G, Staberock U, Höflich G, Möller HJ.

Pharmacopsychiatry. 1996 May;29(3):97-102.

PMID:
8738313
20.

Effect of nortriptyline and paroxetine on CYP2D6 activity in depressed elderly patients.

Solai LK, Pollock BG, Mulsant BH, Frye RF, Miller MD, Sweet RA, Kirshner M, Sorisio D, Begley A, Reynolds CF 3rd.

J Clin Psychopharmacol. 2002 Oct;22(5):481-6.

PMID:
12352271

Supplemental Content

Support Center